Related Experiment Video
Updated: Apr 11, 2026

Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
Published on: April 2, 2018
Genomic characterization of aggressiveness in pituitary neuroendocrine tumors (PitNETs)
Nesrine Benanteur1, Chiara Villa1,2, Fabio Bioletto1,3
1CNRS UMR8104, INSERM U1016, Institut Cochin, Université Paris Cité, Paris, 75014, France.
Background:
Aggressive evolution of PitNETs is rare, metastatic spread even more. Defining aggressiveness and malignancy is challenging, subsequently hard to predict, and to understand. The aim was to provide a molecular definition of aggressiveness using genomic approaches.
Methods:
PitNETs from 206 patients were included. Associations between 9 clinicopathological features of aggressiveness and PitNETs' omics were explored. Omics included transcriptome, DNA methylation, chromosomal alterations and mutations. Clonal tumor evolution was monitored in 7 patients.
Results:
Among the 9 clinicopathological features of aggressiveness, only rapid progression, progression after radiotherapy, Ki67/MIB1 proliferation index ≥10%, temozolomide treatment, metastases and specific death were associated with specific omics signatures, while tumour maximal diameter ≥40mm, cavernous and sphenoid invasion were not. The omic signatures associated with these features of aggressiveness overlapped but remained distinct between corticotroph and mammo-somato-thyrotroph lineages. For each lineage, a common signature of aggressiveness was identified, associating proliferative transcriptome signature and DNA hypermethylation. Alterations in specific genes were associated with aggressive features, - including a novel PitNET gene, LRP1B, and known cancer genes (TP53, CDKN2A) -, while USP8 and GNAS alterations were not. Integration of gene alterations with methylome and transcriptome signatures isolated a subset of molecularly aggressive PitNETs. Molecular signatures were globally stable during the course of the disease, despite evolution towards aggressiveness and potential clonal divergence.
Conclusion:
This systematic analysis of clinicopathological features of aggressiveness using an integrated multiomic approach establishes a histomolecular definition of aggressiveness in PitNETs. Prospective cohorts studies are needed to validate these molecular signatures and establish their prognostic value.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021